Literature DB >> 28248186

Influence of treatment on the outcome of dogs with incompletely excised grade-2 mast cell tumors.

S Vincenti1, F Findji1.   

Abstract

INTRODUCTION: In this study we compared the outcomes of dogs with incompletely-excised grade-2 mast cell tumors (incompletely- excised grade-2 MCTs) either adjuvantly treated or not. Dogs with a grade-2 mast cell tumour (MCT) excised either incompletely or with narrow (.

Entities:  

Keywords:  Hunden; Mastzelltumoren; Rändern,zzm321990Rezidiv; Therapie; dogs; margins; mast cell tumors; recurrence,zzm321990therapy

Mesh：

Substances：

Year:  2017        PMID： 28248186     DOI： 10.17236/sat00109

Source DB:  PubMed          Journal:  Schweiz Arch Tierheilkd        ISSN： 0036-7281            Impact factor:   0.845


  4 in total

1.  Predictive ability of fine-needle aspirate cytology for incompletely resected mast cell tumor surgical sites.

Authors:  Christopher E Lee; Stephanie S Lindley; Annette N Smith; Philippe Gaillard; Ralph A Henderson; Brad M Matz
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

2.  Long-term postsurgical outcomes of mast cell tumors resected with a margin proportional to the tumor diameter in 23 dogs.

Authors:  Teruo Itoh; Atsuko Kojimoto; Kazuyuki Uchida; James Chambers; Hiroki Shii
Journal:  J Vet Med Sci       Date:  2020-12-21       Impact factor: 1.267

3.  Evaluation of Tumor Grade and Proliferation Indices before and after Short-Course Anti-Inflammatory Prednisone Therapy in Canine Cutaneous Mast Cell Tumors: A Pilot Study.

Authors:  Shawna Klahn; Nikolaos Dervisis; Kevin Lahmers; Marian Benitez
Journal:  Vet Sci       Date:  2022-06-07

4.  Beclin-1 is a novel predictive biomarker for canine cutaneous and subcutaneous mast cell tumors.

Authors:  Britta J Knight; Geoffrey A Wood; Robert A Foster; Brenda L Coomber
Journal:  Vet Pathol       Date:  2021-09-14       Impact factor: 2.221
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.